US5866363A
(en)
|
1985-08-28 |
1999-02-02 |
Pieczenik; George |
Method and means for sorting and identifying biological information
|
JP2525798B2
(ja)
*
|
1987-03-12 |
1996-08-21 |
第一製薬株式会社 |
ペプチド誘導体
|
US5217869A
(en)
*
|
1987-10-13 |
1993-06-08 |
Terrapin Technologies, Inc. |
Method to produce immunodiagnostic reagents
|
US5300425A
(en)
*
|
1987-10-13 |
1994-04-05 |
Terrapin Technologies, Inc. |
Method to produce immunodiagnostic reagents
|
US5200320A
(en)
*
|
1987-12-07 |
1993-04-06 |
National Jewish Center For Immunology And Respiratory Medicine |
Method for identifying useful polypeptide vaccines
|
US5266684A
(en)
*
|
1988-05-02 |
1993-11-30 |
The Reagents Of The University Of California |
Peptide mixtures
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
US5744101A
(en)
*
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
US6919211B1
(en)
*
|
1989-06-07 |
2005-07-19 |
Affymetrix, Inc. |
Polypeptide arrays
|
US6040138A
(en)
*
|
1995-09-15 |
2000-03-21 |
Affymetrix, Inc. |
Expression monitoring by hybridization to high density oligonucleotide arrays
|
US6551784B2
(en)
|
1989-06-07 |
2003-04-22 |
Affymetrix Inc |
Method of comparing nucleic acid sequences
|
US6379895B1
(en)
|
1989-06-07 |
2002-04-30 |
Affymetrix, Inc. |
Photolithographic and other means for manufacturing arrays
|
US5424186A
(en)
*
|
1989-06-07 |
1995-06-13 |
Affymax Technologies N.V. |
Very large scale immobilized polymer synthesis
|
US6309822B1
(en)
|
1989-06-07 |
2001-10-30 |
Affymetrix, Inc. |
Method for comparing copy number of nucleic acid sequences
|
US5925525A
(en)
*
|
1989-06-07 |
1999-07-20 |
Affymetrix, Inc. |
Method of identifying nucleotide differences
|
US5800992A
(en)
|
1989-06-07 |
1998-09-01 |
Fodor; Stephen P.A. |
Method of detecting nucleic acids
|
US6346413B1
(en)
|
1989-06-07 |
2002-02-12 |
Affymetrix, Inc. |
Polymer arrays
|
US5547839A
(en)
*
|
1989-06-07 |
1996-08-20 |
Affymax Technologies N.V. |
Sequencing of surface immobilized polymers utilizing microflourescence detection
|
US6955915B2
(en)
*
|
1989-06-07 |
2005-10-18 |
Affymetrix, Inc. |
Apparatus comprising polymers
|
US6406844B1
(en)
|
1989-06-07 |
2002-06-18 |
Affymetrix, Inc. |
Very large scale immobilized polymer synthesis
|
EP0486526B2
(de)
|
1989-08-07 |
2001-03-07 |
Peptech Limited |
Bindeligande für tumornekrosisfaktor
|
US5959087A
(en)
*
|
1989-08-07 |
1999-09-28 |
Peptide Technology, Ltd. |
Tumour necrosis factor binding ligands
|
US20030225254A1
(en)
*
|
1989-08-07 |
2003-12-04 |
Rathjen Deborah Ann |
Tumour necrosis factor binding ligands
|
US6506558B1
(en)
|
1990-03-07 |
2003-01-14 |
Affymetrix Inc. |
Very large scale immobilized polymer synthesis
|
US6759392B1
(en)
*
|
1990-06-11 |
2004-07-06 |
Gilead Sciences, Inc. |
High affinity RNA ligands of basic fibroblast growth factor
|
US6177557B1
(en)
|
1990-06-11 |
2001-01-23 |
Nexstar Pharmaceuticals, Inc. |
High affinity ligands of basic fibroblast growth factor and thrombin
|
US5503978A
(en)
*
|
1990-06-11 |
1996-04-02 |
University Research Corporation |
Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase
|
US5543293A
(en)
*
|
1990-06-11 |
1996-08-06 |
Nexstar Pharmaceuticals, Inc. |
DNA ligands of thrombin
|
US5707796A
(en)
*
|
1990-06-11 |
1998-01-13 |
Nexstar Pharmaceuticals, Inc. |
Method for selecting nucleic acids on the basis of structure
|
US5723286A
(en)
|
1990-06-20 |
1998-03-03 |
Affymax Technologies N.V. |
Peptide library and screening systems
|
US5650489A
(en)
*
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
US5476839A
(en)
*
|
1990-07-10 |
1995-12-19 |
Incyte Pharmaceuticals, Inc. |
Basophil granule proteins
|
US6197529B1
(en)
|
1990-11-21 |
2001-03-06 |
Torrey Pines Institute For Molecular Studies |
Linear substituted oligoalkyleneimine libraries
|
JPH05505112A
(ja)
*
|
1990-11-27 |
1993-08-05 |
バイオジェン,インコーポレイテッド |
Aids、arcおよびhiv感染の予防および治療に有用な抗cd4抗体ホモログ
|
AU1248292A
(en)
|
1990-12-06 |
1992-07-08 |
Affymax Technologies N.V. |
Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides
|
ZA924244B
(en)
*
|
1991-06-18 |
1993-12-10 |
Lilly Co Eli |
Rapid synthesis and screening of peptide mimetics
|
US5747253A
(en)
*
|
1991-08-23 |
1998-05-05 |
Isis Pharmaceuticals, Inc. |
Combinatorial oligomer immunoabsorbant screening assay for transcription factors and other biomolecule binding
|
US5698391A
(en)
*
|
1991-08-23 |
1997-12-16 |
Isis Pharmaceuticals, Inc. |
Methods for synthetic unrandomization of oligomer fragments
|
AU2547592A
(en)
*
|
1991-08-23 |
1993-03-16 |
Isis Pharmaceuticals, Inc. |
Synthetic unrandomization of oligomer fragments
|
US5639603A
(en)
*
|
1991-09-18 |
1997-06-17 |
Affymax Technologies N.V. |
Synthesizing and screening molecular diversity
|
DE69217497T2
(de)
*
|
1991-09-18 |
1997-06-12 |
Affymax Tech Nv |
Verfahren zur synthese der verschiedenen sammlungen von oligomeren
|
US6764681B2
(en)
*
|
1991-10-07 |
2004-07-20 |
Biogen, Inc. |
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
|
US5270170A
(en)
*
|
1991-10-16 |
1993-12-14 |
Affymax Technologies N.V. |
Peptide library and screening method
|
US5733731A
(en)
*
|
1991-10-16 |
1998-03-31 |
Affymax Technologies N.V. |
Peptide library and screening method
|
US6468740B1
(en)
|
1992-11-05 |
2002-10-22 |
Affymetrix, Inc. |
Cyclic and substituted immobilized molecular synthesis
|
US6943034B1
(en)
*
|
1991-11-22 |
2005-09-13 |
Affymetrix, Inc. |
Combinatorial strategies for polymer synthesis
|
CA2124087C
(en)
*
|
1991-11-22 |
2002-10-01 |
James L. Winkler |
Combinatorial strategies for polymer synthesis
|
US6849462B1
(en)
|
1991-11-22 |
2005-02-01 |
Affymetrix, Inc. |
Combinatorial strategies for polymer synthesis
|
US5871734A
(en)
*
|
1992-01-13 |
1999-02-16 |
Biogen, Inc. |
Treatment for asthma with VLA-4 blocking agents
|
US5932214A
(en)
*
|
1994-08-11 |
1999-08-03 |
Biogen, Inc. |
Treatment for inflammatory bowel disease with VLA-4 blockers
|
CA2140257A1
(en)
*
|
1992-07-27 |
1994-02-03 |
Lawrence M. Kauvar |
Sorbent families
|
US6503759B1
(en)
|
1992-10-01 |
2003-01-07 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5721099A
(en)
*
|
1992-10-01 |
1998-02-24 |
Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5565324A
(en)
*
|
1992-10-01 |
1996-10-15 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
ATE161730T1
(de)
*
|
1993-02-09 |
1998-01-15 |
Biogen Inc |
Antikörper zur behandlung von insulinabhängigen diabetes
|
US5367053A
(en)
*
|
1993-05-19 |
1994-11-22 |
Houghten Pharmaceuticals, Inc. |
Opioid peptide inhibitors
|
US6632613B1
(en)
|
1993-06-02 |
2003-10-14 |
University Of Utah Research Foundation |
Compositions and kits for fluorescence polarization assay of large molecules
|
US5846731A
(en)
*
|
1993-06-17 |
1998-12-08 |
Torry Pines Institute For Molecular Studies |
Peralkylated oligopeptide mixtures
|
US5480971A
(en)
*
|
1993-06-17 |
1996-01-02 |
Houghten Pharmaceuticals, Inc. |
Peralkylated oligopeptide mixtures
|
US5380668A
(en)
*
|
1993-07-06 |
1995-01-10 |
University Of Utah Research Foundation |
Compounds having the antigenicity of hCG
|
US6576419B1
(en)
*
|
1993-07-23 |
2003-06-10 |
University Of Utah Research Foundation |
Assay procedure using fluorogenic tracers
|
CN1525171A
(zh)
*
|
1993-10-01 |
2004-09-01 |
ŦԼ�и��ױ��Ǵ�ѧ���� |
用标示物编码的多元组合化学库
|
JPH09504522A
(ja)
*
|
1993-10-12 |
1997-05-06 |
グリコメド・インコーポレイテッド |
細胞接着インヒビターの同定に有用なグリコ−ペプチドのライブラリー
|
US5503805A
(en)
*
|
1993-11-02 |
1996-04-02 |
Affymax Technologies N.V. |
Apparatus and method for parallel coupling reactions
|
US6165778A
(en)
*
|
1993-11-02 |
2000-12-26 |
Affymax Technologies N.V. |
Reaction vessel agitation apparatus
|
US6287787B1
(en)
|
1993-11-24 |
2001-09-11 |
Torrey Pines Institute For Molecular Studies |
Dimeric oligopeptide mixture sets
|
WO1995019567A1
(en)
*
|
1994-01-13 |
1995-07-20 |
The Trustees Of Columbia University In The City Of New York |
Synthetic receptors, libraries and uses thereof
|
US5593853A
(en)
*
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
US6936477B2
(en)
*
|
1994-04-13 |
2005-08-30 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5846841A
(en)
*
|
1994-05-20 |
1998-12-08 |
Selectide Corporation |
Motif Libraries
|
US7378236B1
(en)
|
1994-06-17 |
2008-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method for analyzing gene expression patterns
|
US7323298B1
(en)
|
1994-06-17 |
2008-01-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Microarray for determining the relative abundances of polynuceotide sequences
|
US5582997A
(en)
*
|
1994-08-24 |
1996-12-10 |
Torrey Pines Institute For Molecular Studies |
Lysine/leucine polypeptides, mixture sets and libraries thereof
|
US5645996A
(en)
*
|
1994-08-24 |
1997-07-08 |
Torrey Pines Institute For Molecular Studies |
Melittin-related polypeptides, mixture sets and libraries thereof
|
US6020312A
(en)
*
|
1994-09-13 |
2000-02-01 |
Nce Pharmaceuticals, Inc. |
Synthetic antibiotics
|
US5602097A
(en)
*
|
1994-09-13 |
1997-02-11 |
Ceres Technologies, Inc. |
Synthetic antibiotics
|
US5885782A
(en)
*
|
1994-09-13 |
1999-03-23 |
Nce Pharmaceuticals, Inc. |
Synthetic antibiotics
|
US8236493B2
(en)
*
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US5747458A
(en)
*
|
1995-06-07 |
1998-05-05 |
Chiron Corporation |
Urokinase receptor ligands
|
US5958792A
(en)
*
|
1995-06-07 |
1999-09-28 |
Chiron Corporation |
Combinatorial libraries of substrate-bound cyclic organic compounds
|
EP0880598A4
(de)
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
Verfahren zur analyse von nukleinsäure
|
WO1998014569A1
(en)
|
1996-10-02 |
1998-04-09 |
Bloch Donald B |
Leukocyte-specific protein and gene, and methods of use thereof
|
US6096496A
(en)
*
|
1997-06-19 |
2000-08-01 |
Frankel; Robert D. |
Supports incorporating vertical cavity emitting lasers and tracking apparatus for use in combinatorial synthesis
|
US6312689B1
(en)
|
1998-07-23 |
2001-11-06 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR2 antibodies and methods of use therefor
|
MXPA01002111A
(es)
*
|
1998-08-31 |
2003-03-27 |
Biogen Inc |
Metodo para modular celulas t efectoras de memoria y composiciones.
|
ES2319831T3
(es)
|
1998-09-14 |
2009-05-12 |
Board Of Regents, The University Of Texas System |
Metodos de tratamiento de mieloma multiple y resorcion osea inducida por mieloma usando antagonistas de la union receptor/integrina.
|
US6545264B1
(en)
|
1998-10-30 |
2003-04-08 |
Affymetrix, Inc. |
Systems and methods for high performance scanning
|
DE60020366T2
(de)
*
|
1999-06-14 |
2006-02-02 |
Genentech Inc., San Francisco |
Strukturiertes peptidgerüst zur ausstellung von drehung-bibliotheken auf phage
|
US20030166003A1
(en)
*
|
1999-06-14 |
2003-09-04 |
Cochran Andrea G. |
Structured peptide scaffold for displaying turn libraries on phage
|
EP2332578A1
(de)
|
1999-12-16 |
2011-06-15 |
Biogen Idec MA Inc. |
Verfahren zur Behandlung von ischämischen oder hämorrhagischen Traumata des Zentralnervensystems unter Verwendung von Alpha4-Integrin-Antagonisten
|
EP1930023A3
(de)
|
2001-04-09 |
2008-08-06 |
East Carolina University |
Erythropoietin reduziert die Chemotherapie-induzierte in vivo Toxizität
|
US20020169128A1
(en)
*
|
2001-04-09 |
2002-11-14 |
Geroge Sigounas |
Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
|
US6914123B2
(en)
|
2001-04-17 |
2005-07-05 |
Genentech, Inc. |
Hairpin peptides with a novel structural motif and methods relating thereto
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
KR100607612B1
(ko)
|
2001-06-20 |
2006-08-02 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
US20050107595A1
(en)
*
|
2001-06-20 |
2005-05-19 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US7803915B2
(en)
|
2001-06-20 |
2010-09-28 |
Genentech, Inc. |
Antibody compositions for the diagnosis and treatment of tumor
|
US20030013208A1
(en)
*
|
2001-07-13 |
2003-01-16 |
Milagen, Inc. |
Information enhanced antibody arrays
|
US7858095B2
(en)
*
|
2001-07-24 |
2010-12-28 |
Astellas Us Llc |
Method for treating or preventing sclerotic disorders using CD-2 binding agents
|
MXPA04002593A
(es)
|
2001-09-18 |
2004-05-31 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumor.
|
EP1326076A3
(de)
*
|
2001-10-26 |
2004-01-28 |
Millenium Pharmaceuticals, Inc. |
Verfahren zur Identifizierung von Liganden oder Modulatoren von 2871 G-Protein gekoppelten Rezeptoren
|
EP2067472A1
(de)
|
2002-01-02 |
2009-06-10 |
Genentech, Inc. |
Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Tumoren
|
WO2003076585A2
(en)
|
2002-03-08 |
2003-09-18 |
Board Of Regents, The University Of Texas System |
Controlled modulation of amino acid side chain length of peptide antigens
|
JP2005536190A
(ja)
|
2002-04-16 |
2005-12-02 |
ジェネンテック・インコーポレーテッド |
腫瘍の診断と治療のための組成物と方法
|
EP2305710A3
(de)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetische Antikörperphagenbibliotheken
|
EP1540335B1
(de)
|
2002-08-19 |
2010-04-07 |
Helicon Therapeutics, Inc. |
Screening-verfahren für kognitive erweiterungsvorrichtungen
|
WO2004019857A2
(en)
*
|
2002-08-29 |
2004-03-11 |
Genentech, Inc. |
Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
|
US6910785B2
(en)
*
|
2003-01-22 |
2005-06-28 |
Cooper Technologies Company |
Industrial luminaire with prismatic refractor
|
US20040185499A1
(en)
*
|
2003-03-20 |
2004-09-23 |
Jolley Michael E. |
Method of epitope scanning using fluorescence polarization
|
US8613922B2
(en)
|
2003-04-24 |
2013-12-24 |
The University Of North Carolina At Chapel Hill |
Methods for inhibiting diabetic retinopathy with an antibody against integrin associated protein (IAP)
|
DE10329087B4
(de)
*
|
2003-06-27 |
2014-02-13 |
Biomedical International R + D Gmbh |
Antigenhaltige Mikrosphären zur Allergietherapie
|
MX341074B
(es)
|
2003-07-08 |
2016-08-05 |
Genentech Inc |
Polipeptidos heterologos il-17 a/f y usos terapeuticos de los mismos.
|
US20050095648A1
(en)
*
|
2003-10-30 |
2005-05-05 |
Mario Geysen |
Method for designing linear epitopes and algorithm therefor and polypeptide epitopes
|
AU2004291911A1
(en)
|
2003-11-14 |
2005-06-02 |
Children's Medical Center Corporation |
Self-cleaving ribozymes and uses thereof
|
SI2295073T1
(sl)
|
2003-11-17 |
2014-07-31 |
Genentech, Inc. |
Protitelo proti CD22 za zdravljenje tumorja hematopoetskega izvora
|
MXPA06000176A
(es)
|
2003-12-10 |
2006-06-27 |
Millennium Pharm Inc |
Anticuerpos anti-ccr2 humanizados y sus metodos de uso.
|
MXPA06008918A
(es)
*
|
2004-02-06 |
2007-03-07 |
Astellas Llc |
Metodos de tratamiento de trastornos de la piel.
|
US7754769B2
(en)
|
2004-03-02 |
2010-07-13 |
Mcgill University |
Compositions and methods for preventing or treating an inflammatory response
|
KR20070011558A
(ko)
*
|
2004-05-04 |
2007-01-24 |
제네상스 파머슈티컬스, 아이엔씨. |
일배체형 마커 및 치료에 대한 반응을 측정하기 위해 이를이용하는 방법
|
EP1750747A1
(de)
*
|
2004-05-07 |
2007-02-14 |
Astellas US LLC |
Lösliches lfa-3 polypeptid zur behandlung viraler erkrankungen
|
CA2478458A1
(en)
*
|
2004-08-20 |
2006-02-20 |
Michael Panzara |
Treatment of pediatric multiple sclerosis
|
CN101102792A
(zh)
*
|
2004-11-19 |
2008-01-09 |
比奥根艾迪克Ma公司 |
治疗多发性硬化
|
MX2007010922A
(es)
|
2005-03-10 |
2007-10-12 |
Genentech Inc |
Metodos y composiciones para modular la integridad vascular.
|
US8071559B2
(en)
|
2005-05-02 |
2011-12-06 |
Cold Spring Harbor Laboratory |
Compositions and methods for cancer diagnosis and treatment
|
JP2008541781A
(ja)
|
2005-06-06 |
2008-11-27 |
ジェネンテック・インコーポレーテッド |
異なる遺伝子に対するトランスジェニック動物、および遺伝子の特徴づけのためのその使用
|
EP1899376A2
(de)
|
2005-06-16 |
2008-03-19 |
The Feinstein Institute for Medical Research |
Antikörper gegen hmgb 1 und fragmente davon
|
US7931902B2
(en)
|
2005-08-15 |
2011-04-26 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
US8945573B2
(en)
|
2005-09-08 |
2015-02-03 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Targeted identification of immunogenic peptides
|
US20090293137A1
(en)
|
2005-11-21 |
2009-11-26 |
Genentech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
EP3006466B1
(de)
|
2005-12-02 |
2018-08-01 |
Genentech, Inc. |
Zusammensetzungen und verfahren für die behandlung von krankheiten und störungen in zusammenhang mit der zytokinsignalisierung
|
US20080311107A1
(en)
|
2006-02-17 |
2008-12-18 |
Genetech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
EP2007428A2
(de)
|
2006-04-05 |
2008-12-31 |
Genentech, Inc. |
Verfahren zur verwendung von boc/cdo zur modulation der hedgehog-signalisierung
|
CA2649387A1
(en)
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
WO2007134132A2
(en)
*
|
2006-05-12 |
2007-11-22 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
|
US20080015145A1
(en)
*
|
2006-07-11 |
2008-01-17 |
Maria Gyongyossy-Issa |
Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions
|
EP2520935A3
(de)
|
2006-08-09 |
2013-02-13 |
Homestead Clinical Corporation |
Organspezifische Proteine und Verfahren zu deren Verwendung
|
ES2530438T3
(es)
|
2006-09-12 |
2015-03-02 |
Genentech Inc |
Procedimientos y composiciones para el diagnóstico y tratamiento del cáncer de pulmón utilizando el gen de KIT o KDR como marcador genético
|
DK2436781T3
(en)
|
2007-02-22 |
2016-01-11 |
Genentech Inc |
Methods for the detection of inflammatory bowel disease
|
WO2009043104A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Bionomics Limited |
Markers of endothelial cells and uses thereof
|
RU2503460C2
(ru)
|
2007-11-07 |
2014-01-10 |
Дженентек Инк. |
Применение противомикробного полипептида для лечения микробных нарушений
|
US9182406B2
(en)
*
|
2008-08-04 |
2015-11-10 |
Biodesy, Inc. |
Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
|
PE20120341A1
(es)
|
2008-12-09 |
2012-04-24 |
Genentech Inc |
Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t
|
EP2419137A4
(de)
*
|
2009-04-17 |
2013-01-09 |
Biogen Idec Inc |
Zusammensetzungen und verfahren zur behandlung von akuter myelogener leukämie
|
JP5885664B2
(ja)
|
2009-09-25 |
2016-03-15 |
ゾーマ テクノロジー リミテッド |
スクリーニング法
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
EP2494349A4
(de)
*
|
2009-09-29 |
2013-08-07 |
Dart Neuroscience Cayman Ltd |
Gene, verfahren und zusammensetzungen in zusammenhang mit neurogenese und ihrer modulation
|
CA2776386C
(en)
|
2009-10-02 |
2018-02-27 |
The Trustees Of Columbia University In The City Of New York |
Piscine reovirus immunogenic compositions
|
US8697386B2
(en)
|
2009-10-22 |
2014-04-15 |
Genentech, Inc. |
Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
|
EP2501672A4
(de)
*
|
2009-11-12 |
2013-05-01 |
Univ Texas Tech |
Zusammensetzungen und verfahren zur behandlung hyperproliferativer erkrankungen
|
TWI537383B
(zh)
|
2009-11-30 |
2016-06-11 |
建南德克公司 |
診斷及治療腫瘤之組合物及方法
|
SI2536748T1
(sl)
|
2010-02-18 |
2014-12-31 |
Genentech, Inc. |
Nevrogulinski antagonisti in njihova uporaba pri zdravljenju raka
|
JP5988436B2
(ja)
|
2010-02-23 |
2016-09-07 |
ジェネンテック, インコーポレイテッド |
腫瘍の診断と治療のための組成物と方法
|
DK2558499T3
(en)
|
2010-04-16 |
2017-07-24 |
Biogen Ma Inc |
Anti-VLA-4 antibodies
|
KR20130079384A
(ko)
|
2010-05-03 |
2013-07-10 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 조성물 및 방법
|
WO2012071436A1
(en)
|
2010-11-24 |
2012-05-31 |
Genentech, Inc. |
Method of treating autoimmune inflammatory disorders using il-23r loss-of-function mutants
|
AU2012230899A1
(en)
|
2011-03-21 |
2013-10-10 |
Biodesy, Llc |
Classification of kinase inhibitors using nonlinear optical techniques
|
WO2012142526A1
(en)
|
2011-04-14 |
2012-10-18 |
Modiano Jaime |
Use of tumor fas expression to determine response to anti-cancer therapy
|
US9139824B2
(en)
|
2011-04-21 |
2015-09-22 |
The University Court Of The University Of Aberdeen |
Sapolegina protein in for use as a medicament
|
DK3575792T3
(da)
|
2011-05-31 |
2023-02-27 |
Biogen Ma Inc |
Fremgangsmåde til vurdering af risiko for pml
|
ES2708669T3
(es)
|
2011-08-01 |
2019-04-10 |
Hoffmann La Roche |
Procedimientos de tratamiento del cáncer usando antagonistas de unión al eje de PD-1 e inhibidores de MEK
|
KR20140068062A
(ko)
|
2011-09-15 |
2014-06-05 |
제넨테크, 인크. |
분화의 촉진 방법
|
MX2014004426A
(es)
|
2011-10-15 |
2014-07-09 |
Genentech Inc |
Metodos de uso de antagonistas de scd1.
|
RU2014133547A
(ru)
|
2012-01-18 |
2016-03-10 |
Дженентек, Инк. |
Способы применения модуляторов fgf19
|
CN104718220A
(zh)
|
2012-02-11 |
2015-06-17 |
霍夫曼-拉罗奇有限公司 |
R-spondin易位及其使用方法
|
KR20140142293A
(ko)
|
2012-03-16 |
2014-12-11 |
제넨테크, 인크. |
조작된 입체형태적으로-안정화된 단백질
|
US9139863B2
(en)
|
2012-03-16 |
2015-09-22 |
Genentech, Inc. |
Engineered conformationally-stabilized proteins
|
RU2014141018A
(ru)
|
2012-03-16 |
2016-05-10 |
Ф. Хоффманн-Ля Рош Аг |
Способы лечения меланомы ингибиторами рак1
|
CN104583776B
(zh)
|
2012-04-25 |
2016-09-07 |
比奥德赛公司 |
用于检测蛋白质的变构调节剂的方法
|
WO2013170191A1
(en)
|
2012-05-11 |
2013-11-14 |
Genentech, Inc. |
Methods of using antagonists of nad biosynthesis from nicotinamide
|
MY186099A
(en)
|
2012-05-31 |
2021-06-22 |
Genentech Inc |
Methods of treating cancer using pd-l1 axis binding antagonists and vegf antagonists
|
EP2948173A1
(de)
|
2013-01-28 |
2015-12-02 |
Danmarks Tekniske Universitet |
Ein- oder mehrstufige mycobacterium avium subsp. paratuberkulose-subunit-impfstoff
|
KR20150118159A
(ko)
|
2013-02-22 |
2015-10-21 |
에프. 호프만-라 로슈 아게 |
암의 치료 방법 및 약물 내성의 예방 방법
|
WO2014138364A2
(en)
|
2013-03-06 |
2014-09-12 |
Genentech, Inc. |
Methods of treating and preventing cancer drug resistance
|
WO2014153030A2
(en)
|
2013-03-14 |
2014-09-25 |
Genentech, Inc. |
Methods of treating cancer and preventing cancer drug resistance
|
BR112015023140A8
(pt)
|
2013-03-15 |
2018-01-23 |
Genentech Inc |
proteínas de fusão, método para a fabricação da proteína de fusão, composições, ácido nucleico,vetor, célula hospedeira, métodos de produção de uma proteína de fusão, de tratamento da doença inflamatória intestinal, de inibição da infecção microbiana, de tratamento da lesão renal, para acelerar ou melhorar a cicatrização, para a prevenção ou tratamento de uma condição cardiovascular, para tratamento da síndrome metabólica e para tratamento da endotoxemia.
|
RU2015143437A
(ru)
|
2013-03-15 |
2017-04-27 |
Дженентек, Инк. |
Способы лечения рака и предотвращения устойчивости к лекарственным препаратам для лечения рака
|
RU2701378C2
(ru)
|
2013-03-15 |
2019-09-26 |
Дженентек, Инк. |
Биомаркеры и способы лечения связанных с pd-1 и pd-l1 состояний
|
SG11201600310QA
(en)
|
2013-07-16 |
2016-02-26 |
Genentech Inc |
Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors
|
SG11201604875PA
(en)
|
2013-12-17 |
2016-07-28 |
Genentech Inc |
Methods of treating cancer using pd-1 axis binding antagonists and an anti-cd20 antibody
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
US10955422B2
(en)
|
2014-02-27 |
2021-03-23 |
Biogen Ma, Inc. |
Method of assessing risk of PML
|
ES2968749T3
(es)
|
2014-05-05 |
2024-05-13 |
Regeneron Pharma |
Animales con C5 y C3 humanizados
|
JP2017524371A
(ja)
|
2014-05-23 |
2017-08-31 |
ジェネンテック, インコーポレイテッド |
Mitバイオマーカーとその使用方法
|
WO2015191986A1
(en)
|
2014-06-13 |
2015-12-17 |
Genentech, Inc. |
Methods of treating and preventing cancer drug resistance
|
EP3169361B1
(de)
|
2014-07-15 |
2019-06-19 |
F.Hoffmann-La Roche Ag |
Zusammensetzungen zur krebsbehandlung mit pd-1-achsenbindenden antagonisten und mek-inhibitoren
|
EP3188746A4
(de)
|
2014-09-05 |
2018-05-02 |
The Johns Hopkins University |
Capn9/capns2-aktivität als ziel für eine therapeutische strategie zur behandlung von myofibroblastendifferenzierung und assoziierten erkrankungen
|
HRP20221083T1
(hr)
|
2014-11-20 |
2022-11-25 |
F. Hoffmann - La Roche Ag |
Kombinirana terapija bispecifičnom antigen vezujućom molekulom koja aktivira t stanice i antagonistom vezivanja osi pd-1
|
JP2017537929A
(ja)
|
2014-12-05 |
2017-12-21 |
ジェネンテック, インコーポレイテッド |
Pd−1軸アンタゴニスト及びhpk1アンタゴニストを用いたがん治療のための方法及び組成物
|
EP3237906B8
(de)
|
2014-12-23 |
2020-10-28 |
Bluelight Therapeutics, Inc. |
Befestigung von proteinen an schnittstellen zur verwendung in nicht-linearer optischer detektion
|
EP3273974A4
(de)
|
2015-03-26 |
2018-11-07 |
Women and Infants Hospital of Rhode Island Inc. |
Therapie für maligne erkrankungen
|
CA3176224A1
(en)
|
2015-05-22 |
2016-12-01 |
Translational Drug Development Llc |
Benzamide and active compound compositions and methods of use
|
WO2016205681A1
(en)
|
2015-06-19 |
2016-12-22 |
University Of Rochester |
Septin proteins as novel biomarkers for detection and treatment of müllerian cancers
|
CN108184330B
(zh)
|
2015-06-26 |
2021-08-06 |
加利福尼亚大学董事会 |
抗原肽及其用于诊断和治疗自闭症的用途
|
JP2018529719A
(ja)
|
2015-09-30 |
2018-10-11 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
Alk陰性がんを処置するためのpd−1系結合アンタゴニストおよびalk阻害剤の組合せ
|
WO2017079442A1
(en)
|
2015-11-04 |
2017-05-11 |
Icahn School Of Medicine At Mount Sinai |
Methods of treating tumors and cancer, and identifying candidate subjects for such treatment
|
CA3048193A1
(en)
|
2015-12-23 |
2017-06-29 |
Moonshot Pharma Llc |
Methods for inducing an immune response by promoting premature termination codon read-through
|
EP3413921A4
(de)
|
2016-02-09 |
2019-08-14 |
Alexander Krantz |
Ortsselektive funktionalisierung von proteinen mittels spurloser affinitätsmarkierungen
|
EP3448881B1
(de)
|
2016-04-26 |
2023-06-07 |
Icahn School of Medicine at Mount Sinai |
Behandlung von hippo-pfad-mutanten tumoren und verfahren zur identifizierung von probanden als kandidaten für die behandlung
|
US11292801B2
(en)
|
2016-07-05 |
2022-04-05 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
AU2017336523B2
(en)
|
2016-09-28 |
2022-07-21 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
CA3082255A1
(en)
|
2016-11-23 |
2020-06-10 |
Translational Drug Development, Llc |
Benzamide and active compound compositions and methods of use
|
WO2018140510A1
(en)
|
2017-01-25 |
2018-08-02 |
Biogen Ma Inc. |
Compositions and methods for treatment of stroke and other cns disorders
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
US10765762B2
(en)
|
2017-02-27 |
2020-09-08 |
Regeneron Pharmaceuticals, Inc. |
Humanized model of kidney and liver disorders
|
WO2018195472A1
(en)
|
2017-04-21 |
2018-10-25 |
Genentech, Inc. |
Use of klk5 antagonists for treatment of a disease
|
US11236151B2
(en)
|
2017-04-25 |
2022-02-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
|
US11654135B2
(en)
|
2017-06-22 |
2023-05-23 |
Moonshot Pharma Llc |
Methods for treating colon cancer with compositions comprising amlexanox and immune checkpoint inhibitors
|
US11827669B2
(en)
|
2017-07-19 |
2023-11-28 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection
|
WO2019090242A1
(en)
|
2017-11-04 |
2019-05-09 |
Advanced Proteome Therapeutics Inc. |
Composition and method for modifying polypeptides
|
WO2019126472A1
(en)
|
2017-12-22 |
2019-06-27 |
Genentech, Inc. |
Use of pilra binding agents for treatment of a disease
|
WO2020239558A1
(en)
|
2019-05-24 |
2020-12-03 |
Pfizer Inc. |
Combination therapies using cdk inhibitors
|
EP4061413A1
(de)
|
2019-11-20 |
2022-09-28 |
Intervet International B.V. |
Neuartiger impfstoff gegen heamophilus parasuis
|
US20220378899A1
(en)
|
2019-11-20 |
2022-12-01 |
Intervet Inc. |
A novel vaccine against heamophilus parasuis
|
WO2021099446A1
(en)
|
2019-11-20 |
2021-05-27 |
Intervet International B.V. |
A novel vaccine against heamophilus parasuis
|
CN116685325A
(zh)
|
2020-10-20 |
2023-09-01 |
豪夫迈·罗氏有限公司 |
Pd-1轴结合拮抗剂和lrrk2抑制剂的组合疗法
|
WO2022118197A1
(en)
|
2020-12-02 |
2022-06-09 |
Pfizer Inc. |
Time to resolution of axitinib-related adverse events
|
WO2022159414A1
(en)
|
2021-01-22 |
2022-07-28 |
University Of Rochester |
Erythropoietin for gastroinfestinal dysfunction
|
AU2022289684A1
(en)
|
2021-06-09 |
2023-10-05 |
F. Hoffmann-La Roche Ag |
Combination of a particular braf inhibitor (paradox breaker) and a pd-1 axis binding antagonist for use in the treatment of cancer
|
WO2023057882A1
(en)
|
2021-10-05 |
2023-04-13 |
Pfizer Inc. |
Combinations of azalactam compounds with a pd-1 axis binding antagonist for the treatment of cancer
|